Clinical Study on the Efficacy and Safety of Peg Rhg CSF for Autologous Hematopoietic Stem Cell Mobilization in Lymphoma and Multiple Myeloma:a Randomized Controlled, Multicenter Clinical Study

被引:0
|
作者
Zhang, Lingqian [1 ]
Jun, Li [1 ]
Zhang, Wenjun [1 ]
Guo, Bingling [1 ]
Hu, Chongling [1 ]
Quan, Xi [1 ]
Zeng, Chensi [1 ]
Ding, Yao [1 ]
Huang, Dehong [1 ]
Xiao, Chunyan [1 ]
Liu, Jun [1 ]
Wu, Jing [1 ]
Wang, Chaoyu [1 ]
Liang, Xiping [1 ]
Yang, Zailin [1 ]
Liang, Shunsi [1 ]
Hu, Renzhi [1 ]
Liu, Tingting [1 ]
Li, Qiying [1 ]
Li, Jieping [1 ]
Nan, Yingyu [1 ]
Xiang, Ying [1 ]
Liu, Yao [1 ]
机构
[1] Chongqing Univ Canc Hosp, Dept Hematol Oncol, Chongqing, Peoples R China
关键词
PEG rhG CSF; matopoietic stem cell mobilization; ymphoma and Multiple myeloma; inical study;
D O I
10.1182/blood-2023-182517
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [31] A Phase I Study of the Safety and Feasibility of Bortezomib in Combination with G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma
    Ghobadi, Armin
    Fiala, Mark A.
    Uy, Geoffrey L.
    Stockerl-Goldstein, Keith
    Vij, Ravi
    DiPersio, John F.
    BLOOD, 2016, 128 (22)
  • [32] A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
    Ghobadi, Armin
    Fiala, Mark A.
    Rettig, Michael
    Schroeder, Mark
    Uy, Geoffrey L.
    Stockerl-Goldstein, Keith
    Westervelt, Peter
    Vij, Ravi
    DiPersio, John F.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E588 - E593
  • [33] A Retrospective Study on Safety, Efficacy and Cost of the Chemo-Mobilization for Patients Planned to Undergo Autologous Hematopoietic Stem Cell Transplant: The Secom Study
    Issaragrilsil, Surapol
    Goh, Yeow-Tee Y. T.
    Leung, Anskar Y. H.
    Wahid, S. Fadilah S. Abdul
    Cheng, Hwai Tzeng
    BLOOD, 2014, 124 (21)
  • [34] Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim
    Marchesi, Francesco
    Terrenato, Irene
    Papa, Elena
    Tomassi, Martina
    Falcucci, Paolo
    Gumenyuk, Svitlana
    Palombi, Francesca
    Pisani, Francesco
    Renzi, Daniela
    Romano, Atelda
    Spadea, Antonio
    Regazzo, Giulia
    Rizzo, Maria Giulia
    De Rienzo, Mafalda
    Ripellino, Claudio
    Sgromo, Simona
    Viggiani, Caterina
    Ponte, Eleonora
    Kayal, Ramy
    Cordone, Iole
    Foddai, Maria Laura
    Mengarelli, Andrea
    ANNALS OF HEMATOLOGY, 2024, 103 (3) : 947 - 956
  • [35] Efficacy and safety of biosimilar Peg-filgrastim after autologous stem cell transplant in myeloma and lymphoma patients: a comparative study with biosimilar Filgrastim, Lenograstim, and originator Peg-filgrastim
    Francesco Marchesi
    Irene Terrenato
    Elena Papa
    Martina Tomassi
    Paolo Falcucci
    Svitlana Gumenyuk
    Francesca Palombi
    Francesco Pisani
    Daniela Renzi
    Atelda Romano
    Antonio Spadea
    Giulia Regazzo
    Maria Giulia Rizzo
    Mafalda De Rienzo
    Claudio Ripellino
    Simona Sgromo
    Caterina Viggiani
    Eleonora Ponte
    Ramy Kayal
    Iole Cordone
    Maria Laura Foddai
    Andrea Mengarelli
    Annals of Hematology, 2024, 103 : 947 - 956
  • [36] Addition of plerixafor to stem cell mobilization regimens in autologous donors with multiple myeloma and lymphoma can increase the efficacy of stem cell harvesting in poor mobilizers
    Stuempel, J. -P
    Jentzsch, M.
    Ruschpler, E.
    Leiblein, S.
    Franke, G. -N
    Schwind, S.
    Jaekel, N.
    Wang, S. -Y
    Heyn, S.
    Poenisch, W.
    Niederwieser, D.
    Vucinic, V.
    Oncology Research and Treatment, 2015, 38 : 72 - 72
  • [37] Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts
    Shah, Harsh
    Kim, Seongho
    Singh, Paramveer
    Alavi, Asif
    Ratanatharathorn, Voravit
    Ayash, Lois
    Uberti, Joseph
    Deol, Abhinav
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (02) : 198 - 204
  • [38] A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization
    Manko, Joanna
    Walter-Croneck, Adam
    Jawniak, Dariusz
    Grzasko, Norbert
    Gorska-Kosicka, Magdalena
    Cioch, Maria
    Dmoszynska, Anna
    PHARMACOLOGICAL REPORTS, 2014, 66 (02) : 239 - 242
  • [39] A clinical comparison of the efficacy and safety of biosimilar G-CSF and originator G-CSF in haematopoietic stem cell mobilization
    Joanna Manko
    Adam Walter-Croneck
    Dariusz Jawniak
    Norbert Grzasko
    Magdalena Gorska-Kosicka
    Maria Cioch
    Anna Dmoszynska
    Pharmacological Reports, 2014, 66 : 239 - 242
  • [40] Efficacy, Safety and Cost Implications of Outpatient Autologous Hematopoietic Stem Cell Transplant for Multiple Myeloma: A Single Center Experience
    Marini, Jessica
    Maldonado, Andy
    Weeda, Erin R.
    Hashmi, Hamza
    Neppalli, Amarendra K.
    Edwards, Kathy
    BLOOD, 2020, 136